Showing all 3 results
The NGS Colorectal Cancer Panel from Lab Tests Dubai is a state-of-the-art genetic test that decodes the unique mutations in your tumor, unlocking critical insights for personalized treatment, targeted therapy selection, and hereditary risk assessment.
The **Hereditary Cancer Panel 57 ACMG 20 HBOC & 865 Literature-Reviewed Genes** is a comprehensive genetic test designed to assess hereditary cancer risk. It analyzes **57 key genes**, including the **ACMG 20** and **HBOC-related genes**, alongside **865 literature-reviewed genes**, ensuring a thorough evaluation of cancer predisposition. This panel covers a wide range of hereditary cancers, including **breast, ovarian, colorectal, and more**, providing **clinically actionable insights** for early detection and personalized risk management. Utilizing **advanced sequencing technology**, it delivers **high accuracy and reliability**, making it an essential tool for **patients, healthcare providers, and genetic counselors**. Its unique combination of **expert-curated genes and extensive literature review** enhances diagnostic precision, setting it apart as a **cutting-edge solution for hereditary cancer risk assessment**.
The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a cutting-edge genetic test that analyzes key mutations in JAK2, CALR, and MPL, the genes most commonly linked to myeloproliferative disorders. Using advanced next-generation sequencing (NGS), this test provides a highly accurate and efficient way to diagnose and classify MPNs, even when only small or degraded samples are available (as little as 10 ng of DNA or RNA).